13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13D/A Filed 2026-08-25 Event 2026-08-21 SEC 0000921895-26-002310 →

Velan Capital Investment Management LP Edesa Biotech, Inc. EDSA

Stake: Shares: 1,081,385 Class: Common Shares, without par value

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
10 13D/G filings on this issuer
9 other filings besides this one
Filer Track Record
7 filings by this filer
6 other filings in the data moat
Short Interest · settle 2026-08-14
DTC 5.85
208,955 shares short · -3.4% vs prior

Other 13D/G Filings on Edesa Biotech, Inc.

FiledFormFilerStakeShares
2026-08-25 SCHEDULE 13D/A Nijhawan Pardeep 1,164,676 view →
2026-06-18 SCHEDULE 13G INTEGRATED CORE STRATEGIES (US) LLC view →
2026-06-16 SCHEDULE 13D/A Nijhawan Pardeep 1,164,676 view →
2025-02-14 SCHEDULE Nijhawan Pardeep 19.99% 1,596,581 view →
2020-01-23 SC 10379085 Canada Inc. view →
2020-01-16 SC Pardeep Nijhawan Medicine Professional Corp view →
2020-01-16 SC Lumira Capital Investment Management Inc. view →
2019-09-10 SC 10379085 Canada Inc. view →
2019-09-10 SC Inveready Innvierte Biotech II, S.C.R. S.A view →

Other Filings by Velan Capital Investment Management LP

FiledFormIssuerStakeShares
2026-08-17 SCHEDULE 13G Jasper Therapeutics, Inc. view →
2026-07-20 SCHEDULE 13D/A Jasper Therapeutics, Inc. 3,021,915 view →
2024-05-16 SC ALIMERA SCIENCES INC view →
2022-07-12 SC Radius Health, Inc. view →
2022-05-25 SC Radius Health, Inc. view →
2022-03-15 SC Radius Health, Inc. view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →